Futura Medical (FUM) Competitors

GBX 0.60 +0.02 (+3.10%)

As of 08:24 AM Eastern

FUM vs. FAB, RLM, NSCI, CIZ, and GENF

Should you buy Futura Medical stock or one of its competitors? MarketBeat compares Futura Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Futura Medical include Fusion Antibodies (FAB), Realm Therapeutics (RLM), NetScientific (NSCI), Cizzle Biotechnology (CIZ), and Genflow Biosciences (GENF). These companies are all part of the "biotechnology" industry.

How does Futura Medical compare to Fusion Antibodies?

Fusion Antibodies (LON:FAB) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment.

Futura Medical has higher revenue and earnings than Fusion Antibodies. Fusion Antibodies is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fusion Antibodies	£1.60M	9.42	-£4.10M	-£1.50	N/A
Futura Medical	£1.70M	2.05	-£3.88M	-£2.78	N/A

Fusion Antibodies has a net margin of -91.92% compared to Futura Medical's net margin of -534.62%. Fusion Antibodies' return on equity of -210.32% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fusion Antibodies	-91.92%	-210.32%	-63.78%
Futura Medical	-534.62%	-310.00%	-26.59%

7.6% of Fusion Antibodies shares are held by institutional investors. Comparatively, 1.0% of Futura Medical shares are held by institutional investors. 5.9% of Fusion Antibodies shares are held by company insiders. Comparatively, 16.0% of Futura Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Fusion Antibodies has a beta of 1.215, meaning that its share price is 22% more volatile than the broader market. Comparatively, Futura Medical has a beta of 0.013, meaning that its share price is 99% less volatile than the broader market.

In the previous week, Fusion Antibodies' average media sentiment score of 0.00 equaled Futura Medical'saverage media sentiment score.

Company	Overall Sentiment
Fusion Antibodies	Neutral
Futura Medical	Neutral

Summary

Fusion Antibodies beats Futura Medical on 6 of the 11 factors compared between the two stocks.

How does Futura Medical compare to Realm Therapeutics?

Realm Therapeutics (LON:RLM) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

Realm Therapeutics has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Realm Therapeutics' return on equity of 0.00% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Realm Therapeutics	N/A	N/A	N/A
Futura Medical	-534.62%	-310.00%	-26.59%

In the previous week, Realm Therapeutics' average media sentiment score of 0.00 equaled Futura Medical'saverage media sentiment score.

Company	Overall Sentiment
Realm Therapeutics	Neutral
Futura Medical	Neutral

Realm Therapeutics has higher earnings, but lower revenue than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than Realm Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Realm Therapeutics	£501.92K	0.00	N/A	-£17.50	N/A
Futura Medical	£1.70M	2.05	-£3.88M	-£2.78	N/A

1.0% of Futura Medical shares are held by institutional investors. 16.0% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Futura Medical beats Realm Therapeutics on 5 of the 8 factors compared between the two stocks.

How does Futura Medical compare to NetScientific?

Futura Medical (LON:FUM) and NetScientific (LON:NSCI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

NetScientific has lower revenue, but higher earnings than Futura Medical. Futura Medical is trading at a lower price-to-earnings ratio than NetScientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Futura Medical	£1.70M	2.05	-£3.88M	-£2.78	N/A
NetScientific	£1.45M	0.00	-£2.64M	-£0.11	N/A

Futura Medical has a beta of 0.013, meaning that its share price is 99% less volatile than the broader market. Comparatively, NetScientific has a beta of 1.67, meaning that its share price is 67% more volatile than the broader market.

In the previous week, Futura Medical's average media sentiment score of 0.00 equaled NetScientific'saverage media sentiment score.

Company	Overall Sentiment
Futura Medical	Neutral
NetScientific	Neutral

NetScientific has a net margin of -182.91% compared to Futura Medical's net margin of -534.62%. NetScientific's return on equity of -13.70% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Futura Medical	-534.62%	-310.00%	-26.59%
NetScientific	-182.91%	-13.70%	-9.42%

1.0% of Futura Medical shares are held by institutional investors. Comparatively, 14.7% of NetScientific shares are held by institutional investors. 16.0% of Futura Medical shares are held by insiders. Comparatively, 42.4% of NetScientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

NetScientific beats Futura Medical on 8 of the 10 factors compared between the two stocks.

How does Futura Medical compare to Cizzle Biotechnology?

Cizzle Biotechnology (LON:CIZ) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

0.0% of Cizzle Biotechnology shares are held by institutional investors. Comparatively, 1.0% of Futura Medical shares are held by institutional investors. 65.9% of Cizzle Biotechnology shares are held by insiders. Comparatively, 16.0% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Cizzle Biotechnology has higher earnings, but lower revenue than Futura Medical. Cizzle Biotechnology is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cizzle Biotechnology	N/A	N/A	-£2.81K	-£0.17	N/A
Futura Medical	£1.70M	2.05	-£3.88M	-£2.78	N/A

Cizzle Biotechnology has a beta of 0.068073176, indicating that its share price is 93% less volatile than the broader market. Comparatively, Futura Medical has a beta of 0.013, indicating that its share price is 99% less volatile than the broader market.

In the previous week, Cizzle Biotechnology had 1 more articles in the media than Futura Medical. MarketBeat recorded 1 mentions for Cizzle Biotechnology and 0 mentions for Futura Medical. Cizzle Biotechnology's average media sentiment score of 0.00 equaled Futura Medical'saverage media sentiment score.

Company	Overall Sentiment
Cizzle Biotechnology	Neutral
Futura Medical	Neutral

Cizzle Biotechnology has a net margin of 0.00% compared to Futura Medical's net margin of -534.62%. Cizzle Biotechnology's return on equity of 104.99% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cizzle Biotechnology	N/A	104.99%	-31.72%
Futura Medical	-534.62%	-310.00%	-26.59%

Summary

Cizzle Biotechnology beats Futura Medical on 7 of the 11 factors compared between the two stocks.

How does Futura Medical compare to Genflow Biosciences?

Futura Medical (LON:FUM) and Genflow Biosciences (LON:GENF) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment.

Genflow Biosciences has a net margin of 840.76% compared to Futura Medical's net margin of -534.62%. Genflow Biosciences' return on equity of 377.33% beat Futura Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Futura Medical	-534.62%	-310.00%	-26.59%
Genflow Biosciences	840.76%	377.33%	-58.66%

Genflow Biosciences has lower revenue, but higher earnings than Futura Medical. Genflow Biosciences is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Futura Medical	£1.70M	2.05	-£3.88M	-£2.78	N/A
Genflow Biosciences	N/A	N/A	-£1.76M	-£0.33	N/A

1.0% of Futura Medical shares are owned by institutional investors. Comparatively, 0.1% of Genflow Biosciences shares are owned by institutional investors. 16.0% of Futura Medical shares are owned by company insiders. Comparatively, 25.8% of Genflow Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Futura Medical has a beta of 0.013, meaning that its share price is 99% less volatile than the broader market. Comparatively, Genflow Biosciences has a beta of 2.108, meaning that its share price is 111% more volatile than the broader market.

In the previous week, Genflow Biosciences had 1 more articles in the media than Futura Medical. MarketBeat recorded 1 mentions for Genflow Biosciences and 0 mentions for Futura Medical. Futura Medical's average media sentiment score of 0.00 equaled Genflow Biosciences'average media sentiment score.

Company	Overall Sentiment
Futura Medical	Neutral
Genflow Biosciences	Neutral

Summary

Genflow Biosciences beats Futura Medical on 7 of the 11 factors compared between the two stocks.

Get Futura Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FUM vs. The Competition

Export

Metric	Futura Medical	Biotechnology Industry	Medical Sector	LON Exchange
Market Cap	£3.48M	£357.50M	£6.49B	£2.72B
Dividend Yield	4.55%	3.86%	2.67%	6.13%
P/E Ratio	-0.22	3.17	24.40	366.57
Price / Sales	2.05	6,480.08	478.43	86,586.69
Price / Cash	20.43	13.13	43.05	27.87
Price / Book	0.23	84.73	10.30	7.56
Net Income	-£3.88M	-£96.07M	£3.56B	£5.89B
7 Day Performance	-12.06%	-0.29%	-3.01%	-1.35%
1 Month Performance	-14.57%	1.35%	-0.39%	0.44%
1 Year Performance	-93.57%	47.07%	20.03%	69.78%

Futura Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FUM Futura Medical	N/A	GBX 0.60 +3.1%	N/A	-93.6%	£3.48M	£1.70M	N/A	12	Gap Up
FAB Fusion Antibodies	N/A	GBX 12.22 -6.0%	N/A	+79.6%	£15.28M	£1.60M	N/A	48	Positive News Gap Down
RLM Realm Therapeutics	N/A	N/A	N/A	N/A	£13.41M	£501.92K	N/A	N/A
NSCI NetScientific	N/A	N/A	N/A	N/A	£12.81M	£1.45M	N/A	26
CIZ Cizzle Biotechnology	N/A	GBX 3.02 -4.3%	N/A	+62.2%	£11.95M	N/A	N/A	4	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:FUM) was last updated on 6/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Futura Medical (FUM) Competitors

FUM vs. FAB, RLM, NSCI, CIZ, and GENF

How does Futura Medical compare to Fusion Antibodies?

Summary

How does Futura Medical compare to Realm Therapeutics?

Summary

How does Futura Medical compare to NetScientific?

Summary

How does Futura Medical compare to Cizzle Biotechnology?

Summary

How does Futura Medical compare to Genflow Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FUM vs. The Competition

Futura Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Futura Medical (FUM) Competitors

FUM vs. FAB, RLM, NSCI, CIZ, and GENF

How does Futura Medical compare to Fusion Antibodies?

Which has better valuation & earnings, FAB or FUM?

Is FAB or FUM more profitable?

Do insiders and institutionals hold more shares of FAB or FUM?

Which has more volatility & risk, FAB or FUM?

Does the media prefer FAB or FUM?

Summary

How does Futura Medical compare to Realm Therapeutics?

Is RLM or FUM more profitable?

Does the media refer more to RLM or FUM?

Which has preferable valuation and earnings, RLM or FUM?

Do institutionals and insiders hold more shares of RLM or FUM?

Summary

How does Futura Medical compare to NetScientific?

Which has better earnings & valuation, FUM or NSCI?

Which has more volatility and risk, FUM or NSCI?

Does the media favor FUM or NSCI?

Is FUM or NSCI more profitable?

Do institutionals and insiders believe in FUM or NSCI?

Summary

How does Futura Medical compare to Cizzle Biotechnology?

Do institutionals and insiders have more ownership in CIZ or FUM?

Which has better valuation and earnings, CIZ or FUM?

Which has more volatility & risk, CIZ or FUM?

Does the media refer more to CIZ or FUM?

Is CIZ or FUM more profitable?

Summary

How does Futura Medical compare to Genflow Biosciences?

Is FUM or GENF more profitable?

Which has better earnings and valuation, FUM or GENF?

Do insiders & institutionals believe in FUM or GENF?

Which has more risk & volatility, FUM or GENF?

Does the media prefer FUM or GENF?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FUM vs. The Competition

Futura Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools